Page 2 - Environmental Life Sciences Engineering News Today

Researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, in collaboration with Singapore Centre for Environmental Life Sciences Engineering (SCELSE) and Massachusetts Institute of Technology (MIT), have developed a novel method capable of identifying contaminants in T-cell cultures within 24 hours.

NTU Singapore scientists find both potential threats and promising resources in the thriving colonies of bacteria and fungi on ocean plastic trash

Researchers from the antimicrobial resistance (AMR) interdisciplinary research group in the Singapore-MIT Alliance for Research and Technology (SMART),

Researchers discovered a stress signaling system that enables bacteria to adapt and protect themselves against the immune system and certain antibiotics. The discovery of RlmN as a stress sensor reveals a new mechanism of antimicrobial resistance that can be targeted for drug development.

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in collaboration with Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University Singapore (NTU Singapore) and Massachusetts Institute of Technology (MIT), have discovered a new stress signaling system that enables bacteria cells to adapt and protect themselv...

A new stress signaling system that enables bacteria cells to adapt and protect themselves against the immune system and certain antibiotics. 

Energy is saved because the microbes require only 40 deg C for the recycling process. Read more at straitstimes.com.

Murky wastewater from washing uncooked staples like rice or soybeans may eventually become ‘microbial factories to grow food for fish at an industrial scale.

Researchers developed a combination therapy using the anticancer agent mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating vancomycin-resistant Enterococcus faecalis or VRE.

Researchers developed a combination therapy using the anticancer agent mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating vancomycin-resistant Enterococcus faecalis or VRE.